These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31257462)
1. MicroRNA‑873 inhibits the progression of thyroid cancer by directly targeting ZEB1. Jiao D; Guo F; Fu Q Mol Med Rep; 2019 Aug; 20(2):1986-1993. PubMed ID: 31257462 [TBL] [Abstract][Full Text] [Related]
2. microRNA‑574 inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting zinc finger E‑box‑binding homeobox 1. Mao Y; Wei F; Wei C; Wei C Mol Med Rep; 2018 Aug; 18(2):1826-1834. PubMed ID: 29901177 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
4. microRNA‑211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1. Chen G; Huang P; Xie J; Li R Mol Med Rep; 2018 Jan; 17(1):1275-1282. PubMed ID: 29115509 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-454 inhibits tumor cell proliferation, migration and invasion by downregulating zinc finger E‑box‑binding homeobox 1 in gastric cancer. Song Z; Li W; Wang L; Jia N; Chen B Mol Med Rep; 2017 Dec; 16(6):9067-9073. PubMed ID: 29039488 [TBL] [Abstract][Full Text] [Related]
6. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1. Li G; Xu Y; Wang S; Yan W; Zhao Q; Guo J Pathol Res Pract; 2019 Jan; 215(1):34-39. PubMed ID: 30455125 [TBL] [Abstract][Full Text] [Related]
7. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway. Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L Int J Oncol; 2019 May; 54(5):1809-1820. PubMed ID: 30816476 [TBL] [Abstract][Full Text] [Related]
9. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1. Lin Z; Chen Y; Lin Z; Chen C; Dong Y IUBMB Life; 2018 Oct; 70(10):1032-1039. PubMed ID: 30194893 [TBL] [Abstract][Full Text] [Related]
10. miR-429 suppresses cell growth and induces apoptosis of human thyroid cancer cell by targeting ZEB1. Wu G; Zheng H; Xu J; Guo Y; Zheng G; Ma C; Hao S; Liu X; Chen H; Wei S; Song X; Wang X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):548-554. PubMed ID: 30849921 [TBL] [Abstract][Full Text] [Related]
11. miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1. Sun X; Li Y; Yu J; Pei H; Luo P; Zhang J Jpn J Clin Oncol; 2015 May; 45(5):474-82. PubMed ID: 25921099 [TBL] [Abstract][Full Text] [Related]
12. PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma. Feng G; Chen C; Luo Y Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859611 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1. He J; Xiang D; Lin Y Mol Med Rep; 2019 May; 19(5):3948-3954. PubMed ID: 30864726 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA KIF4A promotes cell migration, invasion and inhibits apoptosis through miR-152/ZEB1 axis in breast cancer. Jin Y; Yang L; Li X; Liu F Diagn Pathol; 2020 May; 15(1):55. PubMed ID: 32408908 [TBL] [Abstract][Full Text] [Related]
15. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
16. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1. Niu K; Shen W; Zhang Y; Zhao Y; Lu Y Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944 [TBL] [Abstract][Full Text] [Related]
17. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. Jiang X; Zhou Y; Sun AJ; Xue JL J Cell Physiol; 2018 Nov; 233(11):8558-8566. PubMed ID: 29323713 [TBL] [Abstract][Full Text] [Related]
18. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1. Li YJ; Ping C; Tang J; Zhang W Cell Biol Int; 2016 Jun; 40(6):621-8. PubMed ID: 26801503 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-199b targets the regulation of ZEB1 expression to inhibit cell proliferation, migration and invasion in non‑small cell lung cancer. Wang J; Zhou F; Yin L; Zhao L; Zhang Y; Wang J Mol Med Rep; 2017 Oct; 16(4):5007-5014. PubMed ID: 28849018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]